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ABSTRACT
Maintaining optimal bone health prevents major bone disorders (e.g., osteoporosis) and prolongs longevity.
Quercetin is a plant-based flavonoid that is suggested to have anti-inflammatory effects and may improve
bone health. PURPOSE: To investigate the effects of quercetin supplementation over 90-days on prominent
bone turnover markers (BTMs), inflammatory markers, bone mineral density (BMD), body composition, and
physical functioning in postmenopausal women. METHODS: Thirty-three healthy, nonosteoporotic,
postmenopausal women (59.2±7.0 years) participated in a double-blind, placebo-controlled investigation.
Participants were randomized into one of two supplement groups: 1) 500 mg of quercetin (QUE) once daily
or 2) 500 mg of methylcellulose (placebo; PLB) once daily. Pre- and post-testing visits included assessments
of BTMs (i.e., osteocalcin [OC], procollagen type-I N-terminal propeptide [PINP], and type-I collagen crosslinked C-terminal telopeptide [CTX]), inflammatory markers (i.e., interleukin [IL]-6, tumor necrosis factoralpha [TNF-], and C-reactive protein [CRP]), BMD measurements, body composition measurements (i.e.,
body fat percentage), and physical function. RESULTS: The QUE group increased OC (p=0.016; d=0.89),
PINP (p=0.030; d=0.64), and CTX (p=0.023; d=0.91) levels and decreased IL-6 (p=0.045; d=0.73) and TNF (p=0.021; d=0.90) levels compared to PLB. CRP (p=0.448; d=0.34), BMD, body composition, and physical
function remained unchanged. CONCLUSION: The results indicate that QUE may maintain optimal bone
health by mediating bone formation and decreasing pro-inflammatory cytokines.
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